Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007378
Filing Date
2022-05-04
Accepted
2022-05-04 16:07:28
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycn-20220331.htm   iXBRL 10-Q 1441717
2 EX-10.1 cycn-ex10_1.htm EX-10.1 24048
3 EX-10.2 cycn-ex10_2.htm EX-10.2 110988
4 EX-10.6 cycn-ex10_6.htm EX-10.6 36298
5 EX-31.1 cycn-ex31_1.htm EX-31.1 14645
6 EX-31.2 cycn-ex31_2.htm EX-31.2 14653
7 EX-32.1 cycn-ex32_1.htm EX-32.1 8310
8 EX-32.2 cycn-ex32_2.htm EX-32.2 8312
  Complete submission text file 0000950170-22-007378.txt   5949100

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20220331_cal.xml EX-101.CAL 36983
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20220331_def.xml EX-101.DEF 184024
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20220331.xsd EX-101.SCH 46418
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cycn-20220331_lab.xml EX-101.LAB 406743
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20220331_pre.xml EX-101.PRE 289198
56 EXTRACTED XBRL INSTANCE DOCUMENT cycn-20220331_htm.xml XML 932896
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 22891537
SIC: 2834 Pharmaceutical Preparations